453 related articles for article (PubMed ID: 16804518)
1. A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.
Guzmán M; Duarte MJ; Blázquez C; Ravina J; Rosa MC; Galve-Roperh I; Sánchez C; Velasco G; González-Feria L
Br J Cancer; 2006 Jul; 95(2):197-203. PubMed ID: 16804518
[TBL] [Abstract][Full Text] [Related]
2. Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.
López-Valero I; Saiz-Ladera C; Torres S; Hernández-Tiedra S; García-Taboada E; Rodríguez-Fornés F; Barba M; Dávila D; Salvador-Tormo N; Guzmán M; Sepúlveda JM; Sánchez-Gómez P; Lorente M; Velasco G
Biochem Pharmacol; 2018 Nov; 157():266-274. PubMed ID: 30195736
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cells.
McAllister SD; Chan C; Taft RJ; Luu T; Abood ME; Moore DH; Aldape K; Yount G
J Neurooncol; 2005 Aug; 74(1):31-40. PubMed ID: 16078104
[TBL] [Abstract][Full Text] [Related]
4. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.
Hernán Pérez de la Ossa D; Lorente M; Gil-Alegre ME; Torres S; García-Taboada E; Aberturas Mdel R; Molpeceres J; Velasco G; Torres-Suárez AI
PLoS One; 2013; 8(1):e54795. PubMed ID: 23349970
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids and gliomas.
Velasco G; Carracedo A; Blázquez C; Lorente M; Aguado T; Haro A; Sánchez C; Galve-Roperh I; Guzmán M
Mol Neurobiol; 2007 Aug; 36(1):60-7. PubMed ID: 17952650
[TBL] [Abstract][Full Text] [Related]
6. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
Galanti G; Fisher T; Kventsel I; Shoham J; Gallily R; Mechoulam R; Lavie G; Amariglio N; Rechavi G; Toren A
Acta Oncol; 2008; 47(6):1062-70. PubMed ID: 17934890
[TBL] [Abstract][Full Text] [Related]
7. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G
Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival.
Marcu JP; Christian RT; Lau D; Zielinski AJ; Horowitz MP; Lee J; Pakdel A; Allison J; Limbad C; Moore DH; Yount GL; Desprez PY; McAllister SD
Mol Cancer Ther; 2010 Jan; 9(1):180-9. PubMed ID: 20053780
[TBL] [Abstract][Full Text] [Related]
9. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
[TBL] [Abstract][Full Text] [Related]
10. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C; Salazar M; Carracedo A; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Cancer Res; 2008 Mar; 68(6):1945-52. PubMed ID: 18339876
[TBL] [Abstract][Full Text] [Related]
12. Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma.
López-Valero I; Torres S; Salazar-Roa M; García-Taboada E; Hernández-Tiedra S; Guzmán M; Sepúlveda JM; Velasco G; Lorente M
Biochem Pharmacol; 2018 Nov; 157():275-284. PubMed ID: 30125556
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Blázquez C; Carracedo A; Salazar M; Lorente M; Egia A; González-Feria L; Haro A; Velasco G; Guzmán M
Neuropharmacology; 2008 Jan; 54(1):235-43. PubMed ID: 17675107
[TBL] [Abstract][Full Text] [Related]
14. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Darmani NA
Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
[TBL] [Abstract][Full Text] [Related]
15. Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma.
Lah TT; Novak M; Pena Almidon MA; Marinelli O; Žvar Baškovič B; Majc B; Mlinar M; Bošnjak R; Breznik B; Zomer R; Nabissi M
Cells; 2021 Feb; 10(2):. PubMed ID: 33562819
[TBL] [Abstract][Full Text] [Related]
16. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
17. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids in disguise: Δ9-tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles.
Wiley JL; Marusich JA; Lefever TW; Grabenauer M; Moore KN; Thomas BF
Neuropharmacology; 2013 Dec; 75():145-54. PubMed ID: 23916483
[TBL] [Abstract][Full Text] [Related]
19. Perinatal exposure to Δ9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens.
Lombard C; Hegde VL; Nagarkatti M; Nagarkatti PS
J Pharmacol Exp Ther; 2011 Nov; 339(2):607-17. PubMed ID: 21831965
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cannabinoids against glioblastoma multiforme: A systematic review.
Kyriakou I; Yarandi N; Polycarpou E
Phytomedicine; 2021 Jul; 88():153533. PubMed ID: 33812759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
